ALTREN SOLUTION 0.22%

Riik: Kanada

keel: inglise

Allikas: Health Canada

Osta kohe

Laadi alla Infovoldik (PIL)
04-01-2024

Toimeaine:

ALTRENOGEST

Saadav alates:

AURORA PHARMACEUTICAL, INC.

Annus:

2.2MG

Ravimvorm:

SOLUTION

Koostis:

ALTRENOGEST 2.2MG

Manustamisviis:

ORAL

Ühikuid pakis:

15G/50G

Retsepti tüüp:

Prescription

Terapeutiline rühm:

SWINE (PIGS); HORSES

Toote kokkuvõte:

Active ingredient group (AIG) number: 0116940001

Volitamisolek:

APPROVED

Loa andmise kuupäev:

2021-08-19

Infovoldik

                                version 04 Jan 2024
1 Litre bottle – Center Panel
1 Litre
DIN: 02519135
FOR VETERINARY USE ONLY
POUR USAGE VÉTÉRINAIRE SEULEMENT
PR
ALTREN®
SOLUTION 0.22%
Altrenogest Oral Solution / Solution Orale d’Altrénogest
2.2 mg/mL / 2,2 mg/ml
Oral Progestin/Progestatif oral
WARNINGS:
1.
HORSES:
This drug is not to be administered to horses that are intended to be
slaughtered for use in food.
2.
SWINE:
Treated animals must not be slaughtered for use in food for at least
42 days
after the latest treatment with this drug.
3.
SOME INDIVIDUALS SHOULD NOT HANDLE THIS PRODUCT. SEE PACKAGE ONSERT
FOR COMPLETE
WARNINGS.
4.
ALTRENOGEST IS READILY ABSORBED BY THE SKIN. AVOID CONTACT WITH SKIN
OR EYES AND
ORAL EXPOSURE. WHEN HANDLING THIS PRODUCT OR WHEN TOUCHING
CONTAMINATED
SURFACES OR EQUIPMENT, VINYL, NEOPRENE OR NITRILE PROTECTIVE GLOVES
MUST BE WORN.
LATEX GLOVES ARE NOT PROTECTIVE. ANY EQUIPMENT OR SURFACES THAT COME
IN CONTACT
WITH ALTREN® SHOULD BE ADEQUATELY CLEANED AND DECONTAMINATED TO
PREVENT HUMAN
EXPOSURE.
5.
Women of childbearing age should exercise extreme caution when
handling this
product. Accidental absorption could lead to a disruption of the
menstrual cycle.
6.
EFFECTS IN HUMANS HAVE BEEN REPORTED IN CASE OF ACCIDENTAL EXPOSURE.
MITIGATION
MEASURES ARE RECOMMENDED. SEE PACKAGE ONSERT FOR COMPLETE WARNINGS.
7.
SEE PACKAGE ONSERT FOR EFFECTS OF OVEREXPOSURE.
8.
KEEP OUT OF REACH OF CHILDREN.
version 04 Jan 2024
1 Litre bottle – Left Panel
HORSES
INDICATIONS:
For suppression of estrus in mares.
DOSAGE AND ADMINISTRATION:
Administer orally at the rate of 1mL per 50 kg (110
lbs) body weight (0.044 mg/kg) once daily for 15 consecutive days. See
attached onsert for
complete details.
SWINE
INDICATIONS:
For suppression of estrus in sexually mature gilts.
DOSAGE AND ADMINISTRATION:
Top dress on gilts daily ration at the rate of 6.8 mL
(15 mg) per gilt per day for 14 consecutive days.
STORAGE:
Store between 15 and 30°C. Protect from freezing.
See attached onsert for complete information.
REORDER NO: 22003
Manuf
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik prantsuse 04-01-2024

Otsige selle tootega seotud teateid

Vaadake dokumentide ajalugu